So Ford Equity Research for SD CA has upgraded them to a Strong Buy... Well they did pretty well with their upgrade on WIN ... it's up about 5% since then, their upgrade back in March on VVUS isn't so pretty. Thats down about 30% since they give it a strong buy. Think I'll stick with the big guns to tell us.
$27 is a little low. This week it's likely to sell down on profit taking to maybe $30.50-31.00. Not sure how much lower than that it will go without some negative international news or a general downturn in the markets as a whole. Technicals say "slightly over-bought" and there will be those who take some profits off the table now that the options expired on Friday, new ones now out. Look to buy in around $30-31, then some getting a foothold and before the holidays could run to $40.00.
You must live in Denver and be smoking a lot of dope this AM. The Ebola Virus panic and frenzy is over dude. The company has a conference call scheduled for Wednesday to report the earning (or lack there of) and will need to come clean with the analysts exactly what FDA said and didn't say, and there plans moving forward (which would be to hope they'll be able to restart a Phase I trial). Happy trails.
The ink on tomorrow's news is about to start drying. Congrats to the Longs.. up $0.05 today. Great day and a volume now at 1/6 of it's 10 day average. The June options expire over the weekend, and then those who have money in the options (intuitional folks) will be out. Beginning next Monday - Friday this stock will sell off town to $12... the time has come for the bears to run.
What are you smoking dude? You don't live in Denver do you :-) Cautious rise... they're bleeding out cash through the front door of their office building. Now they're filing a law suit vs. Roxane for patent infringement. That suit will take years (seriously years) to resolve and lots of $$$. They don't have any cash leftover. The company isn't something anyone wants to purchase at this price so they'll only option is a pretty large secondary. Mark my word.. and write it down. Within the next 28 business days you'll see Vanda make an announcement about a $100-$150M secondary priced around $10.50. Then they'll have the cash, be able to fight off the patent issue, do more advertising, do more research for supplemental sNDA submissions.. and then the stock price will start to rise again, but starting from around $10 per share.
This isn't a short term play - or it shouldn't be.. the calls for it to collapse are brewing and it might take 3 weeks, but it will be back down to $10.00. Watch and wait. Thursday and Friday was all about playing around a bit. Now comes the nasty bears ready to rip it into tiny pieces.
Might close at $13 tomorrow. Friday's are always the time to announce a secondary offering :-)
This stock has made quite a run in the past 7 days (up 45-50%). Even under normal circumstances you'd expect some pullback but with lots of moving parts being dropped out there in the news and the fact they're running out of cash.. this could take a nose dive to $10 extremely fast. But as always, time will tell.
I'm in agreement with you. Chart is looking to topple quickly unless some news that no one knows about just pops out. The only reason this thing isn't down $1.00+ today is MM's pushing it higher to squeeze out shorts and gobble up shares to have. Same tactic used when they drive a stock price down to get shares knowing it will soon be climbing to highs, they're driving this up to get shares (and their spread) knowing it will be back down to around $12 very quickly.
You guys need to WAKE UP. Especially the idiot drh.. those PT's of 15 and 24 are from a while ago, before the FDA decision and ADCOM and launch.
The $24 was 4 months ago. Jefferies hasn't updated one in 10 months.
WAKE UP IDIOT
Here's the list prior to the $6 PT issued today.
Feb 13, 2014 Piper Jaffray Maintains Overweight 24.000
Nov 27, 2013 Piper Jaffray Initiates Coverage on Overweight 21.000 View
Aug 1, 2013 Jefferies Maintains Buy 14.000
Jul 30, 2013 Jefferies Maintains Buy 13.000 View
Jun 20, 2013 Jefferies Maintains Buy 11.000
No shares available now even to short. "Hard to Borrow" now and they want a premium to go out and find some for you. Something has to give pretty soon. Either it tanks and tanks hard, or it runs to $15.00. But before it's all said and done they will need to produce numbers (NRx, EPS, etc..). This isn't simply a FDA approval run up anymore. If they can't keep the lights on selling a drug that no one in managed care will reimburse for... it will go to $6.00 just like the analyst says.
ANSWER MY FRIEND IS OUT. It isn't good either... Short interest pushing the dog up, up, up... now look for it to come down, down, down, down, down, down, down, down.... landing around $9.00. They're out of $$$ and going to be selling lots of stock soon to raise capital.
Sentiment: Strong Sell
Oh.. and HRQoL... come on really. The payers are struggling with $85-100K oncolytic agents and immuno-therapeutics for numerous diseases where NO alternatives exist and the HRQoL implications are TREMENDOUS. Still they're not paying or placing them on
third tier. I'm fully in support of HRQoL, PRO, PTCs, CER, etc.. but the gatekeepers and access influencers aren't buying into it and haven't for years.
So is it more results coming out (positive or negative), is it a new trial starting up or is someone buying them or do the shorts know something isn't good and they're adding to their positions.??? Any guesses